Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Blood Cancer Journal|January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Blood Neoplasia|October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United StatesSudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22Hagop M Kantarjian, Wendy Stock, Ryan D Cassaday, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Leukemia & Lymphoma|July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete responseCaner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.
Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid CancerRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapseAnjali S Advani, Mazyar Shadman, Francis Ali-Osman, et al.
Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countriesK N Naresh, S Advani, M Adde, et al.
Pageof 19